CTIS2023-503887-18-00进行中（未招募）1 期
NITRAIS 01/2023
Antibiotice S.A.0 个研究点目标入组 32 人开始时间: 2023年5月17日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetron combination product after a single dose administration to healthy male and female volunteers in an open-label, randomised, single centre, 2-treatment, 4-period, 2 sequence replicative desigHealthy volunteersCTIS2023-504355-28-03Helsinn Healthcare S.A.74
进行中（未招募）
1 期
Bioequivalence study of the oral suspension of netupitant/palonosetron combination product versus the hard capsules of netupitant/palonosetron combination product after a single dose administration to healthy male and female volunteers in an open-label, randomised, single centre, 2-treatment, 4-period, 2 sequence replicative desigHealthy volunteersCTIS2023-504355-28-00Helsinn Healthcare S.A.74
进行中（未招募）
1 期
Clinical trial to compare availability in the body of the active substance nicotine as well as patch adhesion of the newly developed patch LTS Nicotine TTS (18.6 cm2) vs. Nicotinell® (21 mg/24 h) in healthy smokers after single patch applicatiobioequivalence and patch adhesion trialtherapeutical indication not studiedMedDRA version: 20.0Level: PTClassification code: 10057852Term: Nicotine dependence Class: 100000004873MedDRA version: 20.0Level: PTClassification code: 10053325Term: Smoking cessation therapy Class: 100000004865MedDRA version: 20.0Level: LLTClassification code: 10008374Term: Cessation of smoking Class: 10041244CTIS2023-503548-14-00TS LOHMANN Therapie-Systeme AG72
进行中（未招募）
1 期
A randomized, open-label, single dose, 2-way crossover bioequivalence study comparing ticagrelor 90 mg hard capsules (PG402 [Celon Pharma]) vs ticagrelor 90 mg film-coated tablets (Brilique [AstraZeneca AB]) under fasting conditions in healthy volunteersPrevention of atherothrombotic events in adult patients with- acute coronary syndromes (ACS) or- a history of myocardial infarction (MI) and a high risk of developing an atherothrombotic eventMedDRA version: 20.0Level: PTClassification code: 10028596Term: Myocardial infarction Class: 100000004849CTIS2023-504116-14-00Celon Pharma S.A.40
进行中（未招募）
1 期
Incidence of postoperative residual neuromuscular blockade following the administration of rocuronium in thoracic surgical patients: a randomized placebo controlled studyAnesthesia and Analgesia, patient safetyCTIS2023-504745-31-00niversity Of Debrecen75